Abstract
Despite recent diagnostic and therapeutic advances the prognosis of malignant pleural mesothelioma remains extremely poor. We reviewed the role of some classic (i.e. age, gender, histology, staging) and novel clinical (i.e. occult residual disease, quality of life and fluorodeoxyglucose uptake at positron emission tomography) prognosticators. Many biological and genetic machineries have been lately related with the etiology and the natural history of mesothelioma. These new factors might have a significant function in predicting the prognosis of the disease and in the next future they could reveal an important role for targeted therapies.
Keywords: Genetics, prognostic factors, staging, thoracic surgery.
Related Journals
New Emirates Medical Journal
Current Traditional Medicine
Adolescent Psychiatry
Anti-Infective Agents
Current Respiratory Medicine Reviews
Current Psychopharmacology
Endocrine, Metabolic & Immune Disorders - Drug Targets
Current Diabetes Reviews
Infectious Disorders - Drug Targets
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents